Adam Woodrow - Net Worth and Insider Trading

Adam Woodrow Net Worth

The estimated net worth of Adam Woodrow is at least $1 Million dollars as of 2024-11-05. Adam Woodrow is the President & Chief Commercial of Paratek Pharmaceuticals Inc and owns about 651,284 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $1 Million. Details can be seen in Adam Woodrow's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adam Woodrow has not made any transactions after 2022-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Adam Woodrow

To

Adam Woodrow Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adam Woodrow owns 1 companies in total, including Paratek Pharmaceuticals Inc (PRTK) .

Click here to see the complete history of Adam Woodrow’s form 4 insider trades.

Insider Ownership Summary of Adam Woodrow

Ticker Comapny Transaction Date Type of Owner
PRTK Paratek Pharmaceuticals Inc 2023-09-21 President & Chief Commercial

Adam Woodrow Latest Holdings Summary

Adam Woodrow currently owns a total of 1 stock. Adam Woodrow owns 651,284 shares of Paratek Pharmaceuticals Inc (PRTK) as of December 21, 2022, with a value of $1 Million.

Latest Holdings of Adam Woodrow

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRTK Paratek Pharmaceuticals Inc 2022-12-21 651,284 2.23 1,452,363

Holding Weightings of Adam Woodrow


Adam Woodrow Form 4 Trading Tracker

According to the SEC Form 4 filings, Adam Woodrow has made a total of 10 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 6,750 shares on December 21, 2022, which brought Adam Woodrow around $13,433.

Insider Trading History of Adam Woodrow

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Adam Woodrow Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Adam Woodrow Ownership Network

Ownership Network List of Adam Woodrow

No Data

Ownership Network Relation of Adam Woodrow

Insider Network Chart

Adam Woodrow Owned Company Details

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Adam Woodrow is the President & Chief Commercial of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , Chief Development & Regulatory Randall B. Brenner , and director & CEO Evan Loh .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Adam Woodrow made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

Adam Woodrow Mailing Address

Above is the net worth, insider trading, and ownership report for Adam Woodrow. You might contact Adam Woodrow via mailing address: C/o Paratek Pharmaceuticals, Inc., 75 Kneeland Street, Boston Ma 02111.